p53 Expression Predicts Poor Prognosis in R-CHOP Treated De Novo Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Slack, G. W. [1 ]
Tan, K. L. [1 ]
Scott, D. W. [1 ]
Sehn, L. H. [1 ]
Connors, J. M. [1 ]
Gascoyne, R. D. [1 ]
机构：
[1] BC Canc Agcy, Vancovuer, BC, Canada
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1552
引用
收藏
页码：370A / 370A
页数：1
相关论文
共 50 条
  • [21] ACTIVATION OF THE STAT3 SIGNALING PATHWAY PREDICTS POOR SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH R-CHOP
    Huang, X.
    Meng, B.
    Iqbal, J.
    Ding, B.
    Chen, Y.
    Vose, J. M.
    Chan, W. C.
    Ye, H. B.
    Fu, K.
    ANNALS OF ONCOLOGY, 2011, 22 : 127 - 127
  • [22] MYC-Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in de novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    McDonnell, Timothy
    Miranda, Roberto
    Bueso-Ramos, Carlos
    Schlette, Ellen
    Lin, Pei
    Li, Shaoying
    LABORATORY INVESTIGATION, 2018, 98 : 534 - 534
  • [23] MYC-Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in de novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    McDonnell, Timothy
    Miranda, Roberto
    Bueso-Ramos, Carlos
    Schlette, Ellen
    Lin, Pei
    Li, Shaoying
    MODERN PATHOLOGY, 2018, 31 : 534 - 534
  • [24] The Expression of CD44v6 Predicts Poor Outcome in Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP
    Wei, Yongqiang
    Xie, Muchen
    Huang, Fen
    Wei, Xiaolei
    Jing, Hui
    Hao, Xiaoxiao
    Zeng, Hong
    Zhou, Qinjun
    Xu, Linwei
    Feng, Ru
    BLOOD, 2014, 124 (21)
  • [25] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [26] Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP
    Kadota, Tomohiro
    Seo, Sachiko
    Fuse, Hiroe
    Ishii, Genichiro
    Itoh, Kuniaki
    Yano, Tomonori
    Kaneko, Kazuhiro
    Tsukasaki, Kunihiro
    CANCER MEDICINE, 2019, 8 (03): : 982 - 989
  • [27] Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge
    Lavacchi, Daniele
    Landini, Ida
    Perrone, Gabriele
    Roviello, Giandomenico
    Mini, Enrico
    Nobili, Stefania
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [28] Prognostic Impact of Tumor Microenvironment on Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Gomez-Gelvez, J. C.
    Salama, M.
    Cogan, C.
    Leavitt, M.
    Inamdar, K.
    LABORATORY INVESTIGATION, 2013, 93 : 329A - 329A
  • [29] The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady E.
    Song, Moo-Kon
    Ilic, Ivana
    Leppa, Sirpa
    Nurmi, Heidi
    Seki, Ritsuko
    Uccella, Silvia
    Li, Jun-Min
    Treaba, Diana O.
    Stachurski, Dariusz
    Butera, James N.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 413 - 417
  • [30] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Moonho
    Ahn, Yongchel
    Ahn, Heui-June
    Ha, Suk-Hun
    Oh, Ho-Suk
    Song, Jae-Seok
    Park, Woong-Sub
    Yi, Sang-Wook
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3167 - 3175
12345